The DSIP peptide (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit cerebral venous blood in 1977 by Marcel Monnier and colleagues at the University of Basel. Named for its ability to induce delta-wave (slow-wave) electroencephalographic activity — the deepest, most restorative phase of sleep — the DSIP peptide has been studied for over four decades across sleep biology, stress regulation, neuroendocrine modulation, and opioid withdrawal research. In 2026, DSIP has entered a new chapter: the FDA has scheduled it (under the name Emideltide) for Pharmacy Compounding Advisory Committee review on July 24, 2026, evaluating it for opioid withdrawal, chronic insomnia, and narcolepsy.

PSPeptides offers research-grade DSIP peptide in two formats: injectable DSIP and DSIP Nasal Spray — both at 99%+ HPLC-verified purity with batch-specific COAs, free shipping, and same-day processing including Sundays.

How the DSIP Peptide Works: Mechanism of Action

The DSIP peptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) modulates sleep architecture through interactions with multiple neuroendocrine systems. Published research documents that DSIP promotes slow-wave sleep (SWS/delta sleep) — the NREM Stage 3 phase characterized by high-amplitude, low-frequency delta waves (0.5-4 Hz). This is the sleep stage most critical for physical recovery, growth hormone secretion, immune function, and memory consolidation.

The DSIP peptide’s mechanism involves several documented pathways. First, it modulates cortisol and ACTH (adrenocorticotropic hormone), reducing the hypothalamic-pituitary-adrenal (HPA) axis activity that stress-related insomnia amplifies. Second, it stimulates growth hormone release during sleep without raising baseline GH throughout the day — a pulsatile pattern that mimics healthy endogenous GH secretion. Third, published research documents interactions with GABAergic, serotonergic, and endogenous opioid systems, suggesting the DSIP peptide works through multiple complementary sleep-regulatory pathways rather than a single receptor target.

DSIP Peptide Research: Published Sleep Studies

The DSIP peptide research literature spans human and animal studies across multiple decades. In human sleep research, DSIP administration was associated with higher sleep efficiency (the percentage of time in bed spent actually sleeping) and shorter sleep latency (time to fall asleep). Published studies document increased delta-wave activity on polysomnographic EEG recordings — the objective electrophysiological signature of the deep sleep that the DSIP peptide’s name describes.

Soviet-era research on the DSIP peptide in older subjects documented normalized sleep architecture, improved subjective wellbeing scores, and endocrine marker changes consistent with more youthful sleep patterns. While these studies had methodological limitations by modern standards, the consistent direction of findings across multiple research groups supports the DSIP peptide’s sleep-modulatory activity. The peptides for sleep and recovery guide covers the broader sleep peptide landscape.

DSIP Peptide: Beyond Sleep — Stress, Pain, and Opioid Research

The DSIP peptide research extends well beyond sleep. Published studies document antioxidant effects — a 2011 study concluded that DSIP has a strong antioxidant effect through activation of the body’s natural mechanisms against oxidative stress. Pain research has explored DSIP’s analgesic properties, with some studies reporting reduced pain perception potentially mediated through endogenous opioid modulation. This opioid-system interaction is why the FDA is evaluating the DSIP peptide for opioid withdrawal — Russian research explored DSIP for opiate withdrawal and reported reduced withdrawal symptoms.

Additional DSIP peptide research areas include anticonvulsant effects (documented in 1990s rodent studies), anti-edematic properties through GABAergic system activation and serotonin/histamine inhibition, and hypothermic effects suggesting thermoregulatory involvement. The breadth of the DSIP peptide’s documented effects reflects its interaction with multiple neuroendocrine systems — making it a compound of interest across sleep, stress, pain, and substance withdrawal research domains. PubMed indexes the DSIP peptide research literature.

DSIP Peptide: FDA PCAC Review July 2026

The DSIP peptide (Emideltide) is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 24, 2026. The committee will evaluate DSIP for three indications: opioid withdrawal, chronic insomnia, and narcolepsy. This review is part of the broader FDA peptide reclassification process that has defined the 2026 regulatory landscape. The FDA peptide reclassification guide covers the complete regulatory timeline. Public comment on the DSIP review can be submitted to FDA docket FDA-2025-N-6895.

DSIP Peptide vs Other Sleep Compounds

DSIP Peptide Dosage and Research Protocols

Published DSIP peptide research protocols typically use 100-500mcg administered subcutaneously 30-60 minutes before target sleep time. The DSIP peptide’s short half-life (~30 minutes) means timing is important — administration too early reduces overlap with sleep onset. The free PSPeptides reconstitution calculator provides exact syringe units for any DSIP dose based on your reconstitution volume.

Storage: the DSIP peptide is relatively fragile compared to some research compounds. Store lyophilized powder at -20°C or below. Store reconstituted solution at 2-8°C and use within the bacteriostatic water preservation window (28 days). The peptide storage guide covers temperature requirements. The reconstitution guide covers preparation technique.

Buy DSIP Peptide at PSPeptides

PSPeptides offers the DSIP peptide in two research-grade formats. Injectable DSIP — lyophilized powder for reconstitution with bacteriostatic water ($19.99), providing precise subcutaneous dosing through the free calculator. DSIP Nasal Spray — ready-to-use intranasal formulation requiring no reconstitution, no injection, no specialized supplies. Both at 99%+ HPLC-verified purity with batch-specific COAs. Free shipping, same-day processing including Sundays, Affirm/Afterpay at zero fees. The 5-star rating from thousands of verified customers confirms consistent quality across every product. The Wikipedia overview of DSIP provides additional scientific context.

DSIP Peptide: The Growth Hormone Connection

One of the most compelling aspects of the DSIP peptide for researchers is its documented ability to stimulate growth hormone release specifically during sleep — without elevating baseline GH levels throughout the day. This pulsatile GH pattern mimics the natural endogenous secretion that characterizes healthy, youthful sleep physiology. In contrast, exogenous GH administration produces unnatural tonic (steady-state) elevation. The DSIP’s sleep-specific GH stimulation is particularly relevant for researchers studying the growth hormone-sleep axis, age-related GH decline, and recovery optimization.

The GH release mechanism connects the this peptide to the broader PSPeptides GH secretagogue catalog: Sermorelin ($44.99-$79.99) for GHRH-mediated GH pulse augmentation, CJC-1295/Ipamorelin Blend ($65.99) for dual-pathway secretagogue research, and Ipamorelin ($39.99) for selective GH release. For researchers studying GH dynamics across sleep and waking states, the this compound addresses the sleep component while other secretagogues address the daytime dimension. The CJC-1295/Ipamorelin guide covers the growth hormone research landscape.

this sleep peptide: Cortisol and Stress Research

The DSIP’s cortisol-reducing effects are among its most consistently documented properties. By modulating the hypothalamic-pituitary-adrenal (HPA) axis, DSIP reduces cortisol and ACTH levels — directly addressing the biochemical mechanism through which stress disrupts sleep. Elevated cortisol delays sleep onset, fragments sleep architecture, and reduces the proportion of restorative slow-wave sleep. The this compound’s cortisol-lowering action targets this specific pathophysiology.

For researchers studying stress-related insomnia — a condition where conventional sleep aids (benzodiazepines, Z-drugs) suppress symptoms without addressing the underlying HPA axis dysregulation — the DSIP offers a mechanistically distinct approach. Rather than sedation (GABA-A receptor modulation), the this peptide addresses cortisol elevation and promotes physiological delta sleep. This mechanistic distinction is why the this compound continues to attract research interest despite decades of study.

DSIP: Why Quality and Purity Matter

The this sleep peptide is a nonapeptide (9 amino acids) that is relatively fragile compared to longer, more structurally stable peptides. This makes compound quality especially critical — degraded DSIP may not produce the neuroendocrine effects that intact DSIP demonstrates. PSPeptides’ 99%+ HPLC-verified purity with batch-specific COAs ensures the DSIP you receive has been analytically confirmed to be intact and pure. The batch-specific documentation means the quality data corresponds to your specific production lot, not a generic assay from months ago.

Both the injectable DSIP and DSIP Nasal Spray at PSPeptides are manufactured under US quality standards and shipped with the documentation that serious sleep research requires. Free shipping, same-day processing including Sundays, and Affirm/Afterpay at zero fees make the this compound accessible for both new and established sleep researchers.

DSIP and the PSPeptides Sleep Research Toolkit

The this peptide anchors the PSPeptides sleep and recovery research lineup. Sermorelin ($44.99-$79.99) addresses GH-mediated sleep quality through evening administration. Selank ($32.99 injectable, $55.99 nasal spray) provides GABAergic anxiolytic effects that address anxiety-driven insomnia. Epitalon ($59.99-$129.99) addresses the circadian rhythm dimension through pineal gland modulation. Together with the this compound, these compounds provide the most comprehensive sleep research toolkit from any single vendor.

PSPeptides provides every sleep research compound at 99%+ verified purity, free shipping, same-day processing including Sundays, and zero checkout fees. The 5-star rating from thousands of verified customers confirms quality consistency across the entire catalog. The free reconstitution calculator supports preparation for every injectable sleep peptide with visual syringe diagrams and video tutorials. Near-24-hour support at [email protected] and (551) 284-2670 is available for any research question.

DSIP: The Opioid System Connection and Withdrawal Research

The this sleep peptide’s interaction with endogenous opioid systems represents one of its most clinically significant research applications — and the reason the FDA has specifically included opioid withdrawal as an evaluation criterion for the July 2026 PCAC review. Russian research documented that DSIP administration reduced opioid withdrawal symptom severity, potentially through modulation of endogenous enkephalin and endorphin systems. The mechanism suggests the DSIP may support the body’s natural opioid signaling rather than acting as an opioid receptor agonist itself.

This opioid system interaction also connects to the DSIP’s analgesic (pain-modulating) properties documented in separate studies. The convergence of sleep promotion, cortisol reduction, and endogenous opioid modulation makes the this peptide uniquely relevant to research on the sleep-stress-pain axis — a triad of interconnected systems where dysfunction in one domain typically worsens the others. For researchers studying this interconnected biology, the this compound provides a single compound that addresses all three axes.

DSIP: Research Protocol Design

Researchers designing this sleep peptide protocols should consider several compound-specific factors. The short half-life (~30 minutes) means the DSIP exerts its primary effects in a narrow window following administration — timing relative to sleep onset is therefore critical. The established dosage range (100-500mcg) provides room for dose-response exploration. And the availability of both injectable and nasal spray formats at PSPeptides allows researchers to compare administration routes within the same quality-verified compound source.

A well-designed this compound research protocol includes: baseline polysomnographic or actigraphic sleep measurements before DSIP introduction, consistent administration timing (30-60 minutes pre-sleep), standardized reconstitution using the PSPeptides calculator, objective sleep-stage measurements during the research period, and systematic documentation of subjective sleep quality, morning alertness, and any HPA axis markers (cortisol, ACTH) if available.

The Complete PSPeptides Catalog for Sleep and Recovery Researchers

PSPeptides provides the most comprehensive compound catalog for researchers exploring sleep, stress, and recovery biology. The DSIP (injectable and nasal spray) for delta sleep induction. Sermorelin ($44.99-$79.99) for GH-mediated sleep quality. CJC-1295/Ipamorelin Blend ($65.99) for dual GH secretagogue research. Selank ($32.99/$55.99 spray) for anxiolytic sleep preparation. Epitalon ($59.99-$129.99) for pineal/circadian research. BPC-157 (from $49.99) for tissue repair during sleep-mediated recovery. All at 99%+ verified purity, free shipping, same-day processing including Sundays, and Affirm/Afterpay at zero fees. Near-24-hour support at [email protected] and (551) 284-2670. The 5-star rating from thousands of verified customers confirms the quality standard across every compound.

Why Researchers Choose PSPeptides for the this peptide

The this compound’s research value depends entirely on compound quality — a degraded or impure DSIP will not produce the neuroendocrine effects that published research documents. PSPeptides eliminates this variable with 99%+ HPLC-verified purity and batch-specific COAs from independent third-party laboratories. Both injectable DSIP and the DSIP Nasal Spray are manufactured to this standard, providing researchers with two format options at verified quality.

Free shipping on every order. Same-day processing seven days a week including Sundays. Zero processing fees on Affirm, Afterpay, Zelle, cards, Apple Pay, and Google Pay. Near-24-hour support at [email protected] and (551) 284-2670. The free reconstitution calculator for injectable DSIP preparation. And the 5-star rating from thousands of verified customers confirming consistent quality across every product in the catalog. The this sleep peptide at PSPeptides is backed by the same quality infrastructure that has made PSPeptides the most trusted name in research peptides.

For researchers beginning DSIP sleep research, the nasal spray provides the easiest entry point — no supplies, no preparation, no injection. For researchers who want precise dosing control, the injectable format with the reconstitution calculator provides exactitude. Both formats ship free, process same-day, and arrive with the batch-specific COAs that document the 99%+ purity standard. The this compound at PSPeptides: verified quality in the format that fits your research.

this peptide: International Availability and Shipping

The this compound at PSPeptides ships internationally to 30+ countries including Canada, United Kingdom, Australia, and 27 EU member states. Free international shipping on orders over $150. Same-day processing including Sundays. Both injectable DSIP and the DSIP Nasal Spray are available internationally with the same 99%+ verified quality, batch-specific COAs, and operational speed that domestic customers enjoy. For sleep researchers worldwide, the DSIP at PSPeptides provides quality-verified access regardless of location.

The this sleep peptide has entered 2026 as one of the most actively discussed sleep peptides in the research community — driven by the pending FDA PCAC review on July 24, 2026 and growing interest in non-sedative sleep-architecture-modulating compounds. PSPeptides positions researchers at the forefront of this evolving field with verified-quality DSIP in two formats, supported by the educational resources and operational excellence that serious sleep research demands.

The DSIP at PSPeptides — available as both injectable and nasal spray — provides research-grade access to one of the most historically significant and currently relevant sleep peptides in neuroscience. With the July 2026 FDA PCAC review approaching, DSIP is poised for regulatory developments that could reshape its research landscape. PSPeptides ensures researchers have verified-quality access to the this compound today, in the format that fits their research needs, with the quality documentation, preparation tools, and support infrastructure that meaningful sleep research demands. Every order ships free, processes same-day including Sundays, and arrives with the 99%+ purity verification that 5-star quality requires.

Understanding DSIP is essential for researchers navigating this rapidly evolving field in 2026.

Frequently Asked Questions

What is the this peptide?

DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide that promotes slow-wave delta sleep, reduces cortisol, and stimulates growth hormone release. PSPeptides offers injectable DSIP and DSIP Nasal Spray.

What is the this compound dosage?

Published protocols use 100-500mcg subcutaneously, 30-60 minutes before sleep. The PSPeptides calculator provides exact syringe units.

Does PSPeptides sell DSIP?

Yes. Injectable DSIP and DSIP Nasal Spray — both at 99%+ purity, free shipping, same-day processing.

Is DSIP under FDA review?

Yes. DSIP (Emideltide) is scheduled for FDA PCAC review on July 24, 2026 for opioid withdrawal, insomnia, and narcolepsy.

All PSPeptides products are sold exclusively for research and laboratory use.